“…In dermatology, studies have shown that HRQOL can be severely reduced in patients with a great variety of different skin diseases such as atopic dermatitis and psoriasis [3], acne vulgaris [4, 5], urticaria [6], skin tumours [7], port wine stains [8], onychomycosis [9]or chronic venous insufficiency and leg ulcers [10, 11, 12, 13]. Domains of everyday life that may be affected by skin diseases include aspects of physical and emotional well-being, the patients’ social life as well as their level of functioning at work or school.…”